HOME >> MEDICINE >> NEWS
UCLA Medical Center becomes first hospital to introduce remote presence robots in ICU

UCLA Medical Center has announced initial clinical tests of the RP-6 mobile robot system in its neurosurgery intensive care unit (ICU). The RP-6 robot, made by InTouch Health Inc. in Santa Barbara, Calif., allows doctors to "virtually" consult with patients, family members and health care staff at a moment's notice, even if miles away from the hospital.

Intensivists -- the physicians who specialize in the care of critically ill patients -- in the neurosurgery department at UCLA are using RP-6 to provide additional monitoring from their homes and offices of ICU patients in response to studies showing that intensivist presence in the ICU can decrease morbidity, mortality, length of stay and cost of care. The project, to be funded through an assistance agreement with the U.S. Army Medical Research and Materiel Command, Telemedicine and Advanced Technology Research Center, located at Ft. Detrick, Md., will be led by professor and Chief of Neurosurgery Dr. Neil Martin, associate professor Dr. Paul Vespa and associate professor Valeriy Nenov, all of the David Geffen School of Medicine at UCLA.

There is a nationwide shortage of intensivists. There are fewer than 6,000 practicing intensivists in the United States today and more than 5 million patients admitted to ICUs annually. Therefore, only about 37 percent of ICU patients receive intensivist care, yet having trained intensivists in the ICU results in better outcomes and decreased length of stay in the ICU and hospital. These specialists are familiar with complications that may occur and are therefore better able to minimize errors.

UCLA will test the RP-6 robot as a way to extend the reach of the intensivist. The patient sees, hears and interacts with the doctor through the nearly 5-foot-6-inch tall robot, which displays a live video image of the physician's face on its monitor/head. The physician, seated at a computer console called a ControlStation, also sees and hears the patient through a liv
'"/>

Contact: Dan Page or Elaine Schmidt
dpage@mednet.ucla.edu
310-794-2265
University of California - Los Angeles
10-Mar-2005


Page: 1 2 3

Related medicine news :

1. Medically supervised drug injection facilities safer for users
2. Medical molecules designed to respond to visible light that can penetrate tissue
3. Philanthropist Paul F. Glenn launches labs for aging research at Harvard Medical School
4. New data on Orqis Medicals Cancion CRS to be reported at ACC
5. Medical technologies may hinder rather than help newborn survival
6. Medical meeting to feature research findings and disease prevention and health promotion sessions
7. LA BioMed Medical/Research briefs January 2005
8. Medical negligence system is secretive, unaccountable and unregulated
9. Dartmouth Medical School receives $1.6 million in AIDS funding
10. LA BioMed Medical/Research Briefs December 2004
11. Rush University Medical Center testing magnetic stimulation for depression

Post Your Comments:
(Date:6/19/2013)... 19, 2013 PrettySkin4Less announces it is ... serums by top skin care manufacturer EMINENCE to ... of vitamins, minerals and active organic ingredients to promote ... many other beauty products offer. For this reason it’s ... , "I like products that do what they ...
(Date:6/19/2013)... 2013 Kleritec, Inc. announced the addition ... http://www.kleritec.com . In the recent expansion Kleritec ... activities packages for pre-school and day care providers. The ... to aid teachers across the United States the ability ... , Included in the art and activities packages is ...
(Date:6/19/2013)... 19, 2013 Amber Roberson with ... Benefits, LLC, Native Care Health, LLC and Medcase, ... Health Underwriters’ (NAHU) new professional development course on ... This continuing education course for agents has been ... receive eleven education credits from the Missouri Department ...
(Date:6/19/2013)... 19, 2013 The Journal of Parasitology ... today’s computer software, it creates questions of ethics. For ... As an already published case shows, scientific publications need ... The Journal of Parasitology features a ... a 2004 article published in the Journal of the ...
(Date:6/19/2013)... online edition of the journal Nature , a ... California, San Diego School of Medicine visually monitored the ... occurs in zebrafish after cardiac ventricular injury. Their ... heart are more plastic, or capable of transformation into ... the research reveals a novel potential source of cells ...
Breaking Medicine News(10 mins):Health News:PrettySkin4Less Launches New Innovative Skin Serums with Active Organic Ingredients to World Wide Consumer Base 2Health News:Kleritec Announces Addition of Educational Products. 2Health News:RWI Benefits, LLC Becomes PPACA Certified 2Health News:Altered Photo in Journal Article Illustrates the Need for Manipulation Guidelines 2Health News:Fate of the heart: Researchers track cellular events leading to cardiac regeneration 2
(Date:6/19/2013)... BURLINGTON, Mass. , June 19, 2013 /PRNewswire/ ... and advisory firms for pharmaceutical and healthcare issues, ... the majority of surveyed U.S. and European rheumatologists ... of the attributes that most influences their prescribing ... U.S. and European rheumatologists, respectively, rank the percentage ...
(Date:6/19/2013)... , June 19, 2013 BD Biosciences, a segment ... ), a leading global medical technology company, today announced the ... the latest in its line of high-performance research flow cytometers. ... high-performance multicolor analysis with the most compact footprint in its ... and a height of 30" (76.2 cm). Recognizing that space ...
(Date:6/19/2013)... PRINCETON, N.J. , June 19, 2013 ... Belrose Pharma, a new specialty pharmaceutical company ... generation of innovative injectable and sustained release ... high unmet medical needs, today announced the ... (Customized Linker Technology®) platform and associated product ...
Breaking Medicine Technology:U.S. and European Rheumatologists Agree That a Therapy's Induction of Remission is One of the Attributes That Most Influences Their Prescribing Decisions in Rheumatoid Arthritis 2New BD Biosciences Flow Cytometry Cell Analyzer Enables Complex Multicolor Experiments in Disease Research 2Belrose Pharma Acquires Enzon's Advanced Drug Formulation Technology and Clinical Assets as Foundation for Driving Development of More Effective Injectable and Sustained Release Therapies 2Belrose Pharma Acquires Enzon's Advanced Drug Formulation Technology and Clinical Assets as Foundation for Driving Development of More Effective Injectable and Sustained Release Therapies 3Belrose Pharma Acquires Enzon's Advanced Drug Formulation Technology and Clinical Assets as Foundation for Driving Development of More Effective Injectable and Sustained Release Therapies 4
Cached News: